FDAnews
www.fdanews.com/articles/200500-establishment-labs-gets-ce-mark-for-silicone-breast-implant

Establishment Labs’ Gets CE Mark for Silicone Breast Implant

December 16, 2020

Establishment Labs Holdings has received CE mark certification for its Motiva Ergonomix2 silicone breast implant platform.

The CE mark allows the breast implant to be used in both reconstructive and aesthetic procedures, and the company expects Motiva Ergonomix2 to become its leading implant product once it is commercialized in the first half of 2021.

The European certification also clears the company’s Motiva Ergonomix2 Diamond breast implant, which will be used with its Motiva Mia minimally invasive breast augmentation system when that is approved.

View today's stories